Cadence Pharmaceuticals: From Startup to Billion Dollar Exit

Join ACG San Diego for breakfast as we hear from Ted Schroeder, former CEO and co-founder of local biopharmaceutical success story Cadence Pharmaceuticals. Ted will share the Cadence story, from its humble 2004 founding and initial funding led by Domain Associates, through the successful product in-licensing from Bristol Meyers Squibb, FDA approval, many rounds of private capital investment, an initial public offering and Nasdaq listing, and its recent $1.4 billion sale to Mallinckrodt plc. The Cadence story has something for everyone – start-ups, raising capital from VCs, pharmaceutical product in-licensing, IPOs, navigating the FDA approval process, managing a salesforce, and selling a company – so don’t miss it.

Location:

March 17, 2015

7:00 a.m. - 9:00 a.m.

Marriott Del Mar

11966 El Camino Real, San Diego, CA 92130

PRICING:
(Early registration until the Friday prior, Standard registration from Saturday to Tuesday)

ACGSD Sponsors: $0

ACGSD Members with Breakfast Meetings Included: $0

ACGSD Members Without Breakfast Meetings Included/Pay As You Attend: $65 early registration, $75 regular registration

ACG Members of Other Chapters: $65 early registration, $75 regular registration

Non-Members and Guests: $85 early registration, $95 regular registration

Register Here: http://www.acg.org/sandiego/events/event.aspx?F_d=03%2f17%2f2015&F_y=201...